Simone Scagnoli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Anti–PD-1 and Anti–PD-L1 in head and neck cancer: a network meta-analysis	FRONTIERS IN IMMUNOLOGY	2021
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting	THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY	2021
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET)	CLINICAL CANCER RESEARCH	2021
Second medical opinion in oncological setting	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2021
5-Fluorouracil degradation rate as a predictive biomarker of toxicity in breast cancer patients treated with capecitabine	JOURNAL OF ONCOLOGY PHARMACY PRACTICE	2020
The agnostic role of site of metastasis in predicting outcomes in cancer patients treated with immunotherapy	VACCINES	2020
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study	EUROPEAN JOURNAL OF CANCER	2020
Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1	FRONTIERS IN IMMUNOLOGY	2020
Exploratory pilot study of circulating biomarkers in metastatic renal cell carcinoma	CANCERS	2020
Tissue immune profile: a tool to predict response to neoadjuvant therapy in triple negative breast cancer	CANCERS	2020
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients	JOURNAL OF PERSONALIZED MEDICINE	2020
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients	JOURNAL OF PERSONALIZED MEDICINE	2020
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: a real-world experience	JOURNAL OF CELLULAR PHYSIOLOGY	2019
Adjuvant chemotherapy in resected colon cancer: when, how and how long?	SURGICAL ONCOLOGY	2019
Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study	TARGETED ONCOLOGY	2018
Burned-out testicular cancer: really a different history?	CASE REPORTS IN ONCOLOGY	2017
Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence	ANNALS OF ONCOLOGY	2017
P-158Radioembolization (SIRT) as a Consolidation Treatment in Colorectal Liver Metastases after First Line Chemotherapy: Efficacy Safety	ANNALS OF ONCOLOGY	2016
Prolactin as a potential negative predictive factor in metastatic non-small cell lung cancers (NSCLC) patients in treatment with Nivolumab (NIVO)	ANNALS OF ONCOLOGY	2016
E50Safety and toxicity in elderly patients in treatment for metastatic colon cancer	ANNALS OF ONCOLOGY	2015

ERC

LS1
LS4_12
LS7
LS7_8
LS7_12

Keywords

Medical Oncology

breast cancer

precision medicine

anticancer immunotherapy

biomarkers tumor

real-world setting